New drugs like Prolonix (Phase III trials) mimic amylin, showing 25% greater craving reduction than GLP-1 agonists alone
Pen designs can require different routines Single-dose autoinjectors and multi-dose dial pens are built around different workflows
Experienced telehealth and obesity physicians support access-maximizing asynchronous care pathways and evidence-based lab flows
To set yourself up for success, focus on following a healthy eating pattern with ample amounts of lean protein, fruits, and vegetables, says Kushner
PMID: 17498508 DOI: 10.1053/j.gastro.2007.03.054 Boer GA et al (2023): Obesity pharmacotherapy: incretin action in the central nervous system
Prior authorization and step therapy, which involves trying more affordable options first, are required